Conversely, Pham previously reported that higher levels of PTEN expression were associated with pancreatic ductal adenocarcinoma (PDAC) progression in 26 cases of Tissue MicroArray (TMA)s, thus suggesting that the number of cases could interfere with the outcome of PTEN analysis [87]. This evidence concerns the gene PTEN and pancreatic ductal adenocarcinoma.